M&A Deal Summary |
|
|---|---|
| Date | 2013-06-04 |
| Target | ProFibrix B.V. |
| Sector | Life Science |
| Buyer(s) | The Medicines Company |
| Sellers(s) | Gilde Healthcare |
| Deal Type | Add-on Acquisition |
| Deal Value | 230M USD |
| Advisor(s) | Barclays Investment Bank (Financial) Dechert (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 62 |
| Revenue | 6M USD (2018) |
The Medicines Company is a provider of solutions in acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The Medicines Company was formed in 1996 and is based in Parsippany, New Jersey. The Medicines was founded in 1996 and is based in Parsippany, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 6 |
| Sector (Life Science) | 3 of 4 |
| Type (Add-on Acquisition) | 2 of 4 |
| Country (Netherlands) | 1 of 1 |
| Year (2013) | 2 of 3 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-01-07 |
Incline Therapeutics
Redwood City, California, United States Incline Therapeutics, Inc. is a company focused on the development of IONSYS® (fentanyl iontophoretic transdermal system), a compact, disposable, needleless Patient-Controlled Analgesia (PCA) system in development for the short-term management of acute postoperative pain in the hospital setting. |
Buy | $185M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-04 |
Rempex Pharmaceuticals
San Diego, California, United States Rempex Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 800M EUR |
| Size | Middle-Market |
| Type | Sector Focused |
Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest up to €30 million in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 2001 and is headquartered in Utrecht, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 30 |
| Sector (Life Science) | 5 of 16 |
| Type (Add-on Acquisition) | 5 of 15 |
| Country (Netherlands) | 1 of 10 |
| Year (2013) | 1 of 2 |
| Size (of disclosed) | 4 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-01-01 |
Sapiens Steering Brain Stimulation
Munich, Germany Sapiens Steering Brain Stimulation GmbH is developing a Deep Brain Stimulation (DBS) system for patients suffering from brain disorders such as Parkinsons disease. Sapiens innovative solution is an advanced DBS lead with 40 individual stimulation points. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-14 |
Conatus Pharmaceuticals
San Diego, California, United States Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Conatus Pharmaceuticals was founded in 2005 and is based in San Diego, California. |
Sell | - |
